Ash 2024 Abstracts. Measurable residual disease in aml in 2024 and beyond oral and poster. Disease burden and minimal residual disease in prognosis and treatment:


Ash 2024 Abstracts

Oral and poster abstracts product theaters scientific. No submissions will be accepted after this deadline.

Ash 2024 Abstracts Images References :